Cargando…
Baseline Serum HE4 But Not Tissue HE4 Expression Predicts Response to the Levonorgestrel-Releasing Intrauterine System in Atypical Hyperplasia and Early Stage Endometrial Cancer
The levonorgestrel-releasing intrauterine system (LNG-IUS) is a conservative management option for atypical hyperplasia (AH) and low grade early stage endometrial cancer (EEC), but around 1 in 3 patients fail to respond to treatment. The aim of this study was to investigate if serum and/or tissue HE...
Autores principales: | Behrouzi, Roya, Ryan, Neil A. J., Barr, Chloe E., Derbyshire, Abigail E., Wan, Y. Louise, Maskell, Zoe, Stocking, Katie, Pemberton, Philip W., Bolton, James, McVey, Rhona J., Crosbie, Emma J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073190/ https://www.ncbi.nlm.nih.gov/pubmed/31979212 http://dx.doi.org/10.3390/cancers12020276 |
Ejemplares similares
-
HE4 as a Biomarker for Endometrial Cancer
por: Behrouzi, Roya, et al.
Publicado: (2021) -
Weight Loss During Intrauterine Progestin Treatment for Obesity-associated Atypical Hyperplasia and Early-Stage Cancer of The Endometrium
por: Barr, Chloe E., et al.
Publicado: (2021) -
Comparison of two immunoassays for the measurement of serum HE4 for ovarian cancer
por: Barr, Chloe E., et al.
Publicado: (2021) -
Urine CA125 and HE4 for the Detection of Ovarian Cancer in Symptomatic Women
por: Barr, Chloe E., et al.
Publicado: (2023) -
Thermodynamic properties of HE3-HE4 solutions with applications to the HE3-HE4 dilution refrigerator
por: Radebaugh, R
Publicado: (1967)